Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - phenoxymethylpenicillin - powder for oral solution - phenoxymethylpenicillin 125 mg/5ml - antibacterials for systemic use

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - phenoxymethylpenicillin potassium - tablet - phenoxymethylpenicillin potassium 280 mg - antibacterials for systemic use

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - phenoxymethylpenicillin - granules for oral solution - phenoxymethylpenicillin 125 mg/5ml - antibacterials for systemic use

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - phenoxymethylpenicillin potassium - oral solution - 50mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - phenoxymethylpenicillin potassium - oral solution - 25mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - phenoxymethylpenicillin potassium - oral solution - 25mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - phenoxymethylpenicillin potassium - oral solution - 50mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - phenoxymethylpenicillin potassium - oral solution - 50mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenoxymethylpenicillin potassium, quantity: 277.18 mg (equivalent: phenoxymethylpenicillin, qty 250 mg) - capsule, hard - excipient ingredients: magnesium stearate; gelatin; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified water - treatment of mild to moderately severe infections due to penicillin senstivie staphylococci, pneumococci, gonococci and haemolytic stretococci infections. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recent streptococcal infections including the prevention of recurrence following rhematic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/pr congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or childbirth.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenoxymethylpenicillin potassium, quantity: 554.37 mg (equivalent: phenoxymethylpenicillin, qty 500 mg) - capsule, hard - excipient ingredients: magnesium stearate; gelatin; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified water - treatment of mild to moderately severe infections due to penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic stretococci infections. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recent streptococcal infections including the prevention of recurrence following rhematic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/pr congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or childbirth.